Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immuno-Biological Laboratories Co., Ltd. (JP:4570)
TSE/TYO:4570
Holding JP:4570?
Track your performance easily
4570 Stock Chart & Stats
Day’s Range¥0 - ¥0
52-Week Range¥358.00 - ¥649.00
Previous Close¥500
Volume19.20K
Average Volume (3M)294.29K
Market Cap
¥4.66B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)20.1
Beta0.58
Next Earnings
Jan 31, 2025EPS EstimateN/A
Last Dividend Ex-Date
Mar 27, 2013Dividend YieldN/A
Share Statistics
EPS (TTM)24.84
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume294,290
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
4570 FAQ
What was Immuno-Biological Laboratories Co., Ltd.’s price range in the past 12 months?
Immuno-Biological Laboratories Co., Ltd. lowest stock price was ¥358.00 and its highest was ¥649.00 in the past 12 months.
What is Immuno-Biological Laboratories Co., Ltd.’s market cap?
Currently, no data Available
When is Immuno-Biological Laboratories Co., Ltd.’s upcoming earnings report date?
Immuno-Biological Laboratories Co., Ltd.’s upcoming earnings report date is Jan 31, 2025 which is in 68 days.
How were Immuno-Biological Laboratories Co., Ltd.’s earnings last quarter?
Immuno-Biological Laboratories Co., Ltd. released its earnings results on Nov 11, 2024. The company reported ¥2.17 earnings per share for the quarter, beating the consensus estimate of N/A by ¥2.17.
Is Immuno-Biological Laboratories Co., Ltd. overvalued?
According to Wall Street analysts Immuno-Biological Laboratories Co., Ltd.’s price is currently Overvalued.
Does Immuno-Biological Laboratories Co., Ltd. pay dividends?
Immuno-Biological Laboratories Co., Ltd. pays a Notavailable dividend of ¥5 which represents an annual dividend yield of N/A. See more information on Immuno-Biological Laboratories Co., Ltd. dividends here
What is Immuno-Biological Laboratories Co., Ltd.’s EPS estimate?
Immuno-Biological Laboratories Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Immuno-Biological Laboratories Co., Ltd. have?
Immuno-Biological Laboratories Co., Ltd. has 9,314,590 shares outstanding.
What happened to Immuno-Biological Laboratories Co., Ltd.’s price movement after its last earnings report?
Immuno-Biological Laboratories Co., Ltd. reported an EPS of ¥2.17 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.162%.
Which hedge fund is a major shareholder of Immuno-Biological Laboratories Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4570
---
Immuno-Biological Laboratories Co., Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technical Analysis
JCR Pharmaceuticals Co., Ltd.
―
Symbio Pharmaceuticals Limited
―
Medrx Co., Ltd.
―
---